Mammography Systems Market Size By Product (Analog Systems, Full Field Digital Mammography System (FFDM), Breast Tomosynthesis System), By Technology (Screen Film, 2D Mammography, 3D Mammography), By End-use (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Competitive Market Share & Forecast, 2021 – 2027

Published Date: Feb 2021  |  Report ID: GMI2637  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 145   |   Base Year: 2020




Summary Table of Contents Industry Coverage Methodology

Industry trends

Mammography Systems Market size was valued at over USD 2 billion in 2020 and is projected to grow at more than 7.8% CAGR between 2021 and 2027. Increasing incidence of cancer cases coupled with rising awareness about early diagnosis of breast cancer are the factors contributing to the market growth. According to the U.S. Breast Cancer Statistics, in 2021, approximately more than 2.8 million new cases of breast cancer are expected to be diagnosed in the U.S. Moreover, rising awareness about mortality associated with breast cancer and importance of early screening will further augment the market expansion.
 

Mammography Systems Market

Get more details on this report - Request Free Sample PDF
 

Major factors contributing to the growth of breast cancer cases are obesity, reduced childbearing, hormone replacement therapy, and age-related risk factors. According to the Centers for Disease Control and Prevention, the prevalence of obesity was 42.4% in the U.S. in 2018. The other factors increasing the breast cancer cases are heredity, radiation exposure, having a first child at an older age, and excessive consumption of alcohol. Thus, with growing number of people with an inclination towards adoption of such lifestyles, the risk of breast cancer is growing consequently, thereby creating demand for breast cancer imaging tools in future.
 

Rising number of product introductions coupled with increasing FDA approvals are the factors contributing to the market revenue. The FDA announced new steps in advancing breast cancer screening and helping patients in acquiring more information pertaining to breast health care. These changes include advancement in tissue density standards and adding a new assessment category. Technological collaboration and availability of breast imaging products are also fuelling the market value.
 

Increasing demand for technologically advanced breast cancer screening is predicted to boost the industry growth

Mammography Systems Market Share

Get more details on this report - Request Free Sample PDF
 

Breast tomosynthesis system segment in the mammography systems market will showcase growth of 9.4% till 2027 led by growing use of the technology in mammography and improved clinical outcome. The technology provides higher diagnostic accuracy and enhanced efficacy compared to other breast imaging technologies. Such factors are estimated to foster the segment growth in the coming years.
 

Continuous improvements in clinical outcomes and high-quality visualization of breast tissues are the factors propelling the breast tomosynthesis systems demand. The device has the capacity to detect cancer at an early stage while reducing the incidence of advanced cancer. The main advantage of device is that it can reduce the masking effects of surrounding fibro glandular tissue, thereby improving visualization of normal tissue and breast lesions.
 

Continuous technological advancement will drive the market demand

3D mammography technology accounted for USD 470 million in 2020 due to continuous technological advancements in the field of 3D mammography. Thus, increasing adoption of innovative breast imaging tools and rising acceptance of DBT devices are contributing to the market growth.
 

The introduction of artificial intelligence (AI) in 3D mammography has reduced mammography exam time without compromising image quality. Furthermore, speedy FDA approval for AI enabled 3D mammography systems is also spurring the market size.
 

Increasing healthcare expenditure coupled with availability of advanced imaging in hospitals will impel the mammography systems market share

The hospitals end-use segment exceeded USD 1.2 billion in 2020 on account of rising number of breast screening procedures in hospitals and the availability of advanced mammography systems.
 

The breast imaging facilities at hospitals provide comprehensive breast care services to women of all ages. The use of multidisciplinary high-technology and patient-centred approach to care are the factors impacting the segment expansion. Moreover, availability of specialized radiologists in hospitals and improved clinical outcome will drive the product demand in the coming years. 
 

Presence of key leaders will positively impact the North America market expansion

North America mammography systems market held 35% of the revenue share in 2020. Presence of a large patient pool and increasing geriatric population are the factors propelling the market revenue. According to the United States Census Bureau, by 2030, all the baby boomers will be older than 65 years in the U.S. Thus, hormonal fluctuations coupled with aging will influence pervasiveness of breast cancer among older women.
 

Presence of large number of local players and increasing number of product launches in the field of mammography are thriving the market value. Additionally, increasing incidence of breast cancer cases in the region are also driving the demand for mammography systems. According to the National Breast Cancer Foundation, Inc., it is estimated that approximately 30% of all new cancer diagnosis is breast cancer. Thus, the presence of large patient pool and availability of advanced mammography solutions in the region will boost the demand.
 

Major market participants are innovating their products to cater to rising demand for effective cancer diagnosis tools

Some of the major companies operating in the market are Hologic, Analogic Corporation, Canon Medical System Corporation, Fujifilm Holdings Corporation, GE healthcare, and others. These leaders are continuously innovating their products and introducing new products in the market. Rising merger & acquisition and license & partnership strategies among these players are also augmenting the industry expansion.
 

Some of the recent industry developments:

  • In December 2019, GE Healthcare launched contrast–enhanced mammography solution for biopsy. The GE Healthcare’s Serena Bright is the first contrast enhanced mammography solution for biopsy, thereby providing edge over other players.
     
  • In March 2019, Fujifilm launched three software tools for its digital mammography systems. The tools are Iterative Super-resolution Reconstruction, S-View, and Tomosynthesis Spot. These tools are designed to provide higher image quality, and lower dose.
     
  • In March 2018, Planmed Clarity 3D digital mammography tomosynthesis system and Planmed Clarity 2D digital mammography system received approval letter from Health Canada for its sale that leads to company’s geographical expansion.
     

Mammography systems market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027 for the following segments:
 

Market, By Product                   

  • Analog Systems
  • Full Field Full Digital Mammography Systems (FFDM)
  • Breast Tomosynthesis System

Market, By Technology

  • Screen Film
  • 2D Mammography
  • 3D Mammography

Market, By End-Use

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
       

Frequently Asked Questions (FAQ) :

Mammography systems market size surpassed USD 2.0 billion in 2020 and is set to record a CAGR of over 7.8% through 2027.
Breast tomosynthesis system segment will witness a 9.4% growth rate through 2027 owing to the growing demand for technologically advanced mammography and improved clinical result.
3D mammography technology segment was valued at USD 470 million in 2020 and will expand owing to the increasing adoption of advanced breast imaging tools and DBT devices.
Mammography systems market recorded a valuation of over USD 1.2 billion from the hospitals segment in 2020 driven by the availability of advanced mammography systems in the facility.
North America accounted for 35% of mammography systems market share in 2020 will grow significantly owing to the presence of a huge patient pool and growing elderly population.

Premium Report Details

  • Published Date: Feb 2021
  • Pages: 145
  • Tables: 88
  • Charts / Figures: 13
  • Companies covered: 13
  • Countries covered: 14

Get a report that explains COVID-19 impact on this market

Buy Now

Need a Discount? Get in touch with us for special pricing

Request Discount

 Connect with our sales team

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X